Paid Clinical Trials in Anchorage, AK
As of July 2026, 96 paid clinical trials are recruiting in Anchorage, Alaska. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Anchorage offers studies at sites including Providence Alaska Medical Center for conditions such as Malignant Solid Neoplasm, Gastroesophageal Junction Adenocarcinoma, Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Anchorage
Trials by drug in Anchorage
Filter results
95 clinical trials
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)
Study With Phage for CF Subjects With Pseudomonas Lung Infection
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Family Communications After Genetic Testing
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Top Research Study Locations in Anchorage
Researchers run research studies in Anchorage, AK at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Providence Alaska Medical Center | Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 44 |
| Katmai Oncology Group | Anatomic Stage II Breast Cancer AJCC v8, Malignant Solid Neoplasm, Stage IV Lung Cancer AJCC v8 | 38 |
| Alaska Women's Cancer Care | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Malignant Female Reproductive System Neoplasm | 38 |
| Alaska Oncology and Hematology LLC | Malignant Solid Neoplasm, Ovarian Carcinoma, Prostate Adenocarcinoma | 33 |
| Alaska Breast Care and Surgery LLC | Malignant Solid Neoplasm, Ovarian Carcinoma, Prostate Adenocarcinoma | 31 |
| Anchorage Associates in Radiation Medicine | Malignant Solid Neoplasm, Ovarian Carcinoma, Prostate Adenocarcinoma | 31 |
| Alaska Oncology and Hematology | Breast Neoplasms, Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung | 9 |
| Anchorage Radiation Therapy Center | Acral Lentiginous Melanoma, Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 | 5 |
| Anchorage Oncology Centre | Acral Lentiginous Melanoma, Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 | 4 |
| Alaska Native Tribal Health Consortium | Child Obesity, Smoking Cessation | 2 |
| Alaska Oncology & Hematology, LLC | B-Cell Non-Hodgkins Lymphoma, Non-small Cell Lung Cancer | 2 |
| Alaska Oncology and Hematology, LLC | Non-small Cell Lung Cancer, Solid Tumours | 2 |
| Southcentral Foundation | Advance Care Planning, Hearing Loss | 2 |
| Alaska Womens Cancer Care | Endometrial Cancer, Malignant Neoplasm | 2 |
| AA Spine & Pain Clinic | Lumbar Spinal Stenosis | 1 |
| Alaska Children's EYE & Strabismus | Bradycardia, Strabismus | 1 |
| Alaska Heart Institute | Obstructive Hypertrophic Cardiomyopathy | 1 |
| Alaska Heart and Vascular Institute | Symptomatic Hypertrophic Cardiomyopathy (HCM) | 1 |
| Alaska Native Medical Center (ANMC) | Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III | 1 |
| Alaska Oncology and Hematology, Llc | HR+/HER2- Breast Cancer | 1 |
| Alaska Womens Cancer Care Akwcc | Ovarian Cancer | 1 |
| Anchorage Native Primary Care Center | Smoking Cessation | 1 |
| Investigative | Solid Tumors | 1 |
| Katmai Oncology Group - Anchorage | Breast Cancer | 1 |
| Ohio State University-Telemedicine | Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer AJCC v8 | 1 |
Active & Upcoming Studies in Anchorage (2026)
Recruiting trials in Anchorage grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (67 active studies)
- Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial · Fred Hutchinson Cancer Center
- BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease · Phase 3 · BeOne Medicines
Mental health & behavior (2 active studies)
- Metabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT) · Southcentral Foundation
- Family-Based Financial Incentives Intervention for Smoking Cessation · Mayo Clinic
Diabetes & metabolic (1 active study)
- More Outside Your Door: a Diet/physical Activity Intervention to Decrease Risk of Obesity in Alaska Native Preschoolers · Alaska Native Tribal Health Consortium
Cardiovascular (1 active study)
Pediatric (1 active study)
Common conditions studied in Anchorage
- Malignant Solid Neoplasm (5 active studies)
- Gastroesophageal Junction Adenocarcinoma (4 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)
- Breast Cancer (3 active studies)
- Non-small Cell Lung Cancer (3 active studies)
- Stage IV Lung Cancer AJCC v8 (3 active studies)
Leading research sponsors in Anchorage
- SWOG Cancer Research Network
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- Children's Oncology Group
- ECOG-ACRIN Cancer Research Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Anchorage?
There are approximately 96 recruiting clinical trials in Anchorage, Alaska listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Anchorage pay participants?
Most recruiting trials in Anchorage compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Anchorage?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Anchorage?
The most common conditions under active study in Anchorage include Malignant Solid Neoplasm (5), Gastroesophageal Junction Adenocarcinoma (4), Anatomic Stage II Breast Cancer AJCC v8 (3), Breast Cancer (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Anchorage?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Anchorage on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Anchorage?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Anchorage?
Recruiting research sites in Anchorage include Providence Alaska Medical Center, Katmai Oncology Group, Alaska Women's Cancer Care, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Anchorage right now?
The largest active categories in Anchorage are Cancer & tumors (67), Mental health & behavior (2), Diabetes & metabolic (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.